Skip to content
15% off your first order15% off your first order

DSIP 5 mg vial

Also known as Delta Sleep-Inducing Peptide

Deep sleep

Investigated for delta-wave sleep and stress signaling.

$59.00CAD· $11.80/mg
1
  • Ships from Canada in 1–2 business days
  • Free shipping over $120
  • Place your order, then send the e-Transfer. We pack it as soon as it arrives.

For research use only. Not for human consumption.

Complete your setup

Needles and wipes are free. Water is $19.

About DSIP

DSIP is a nonapeptide first identified for its association with delta-wave sleep. Research examines its relationship with sleep architecture and with stress-hormone regulation.

How it works

Slow-Wave Sleep
Studied for association with delta-wave activity, the deepest, most restorative phase of the sleep cycle.
Stress Axis
Explored for interaction with the hormonal cascade that governs the stress response.
Read the full research

What you need

  • Bacteriostatic Water
  • Needles
  • Alcohol Wipes
  • A protocol guide comes with every order

Shipping & payment

  • Packed and dispatched within 1–2 business days
  • Delivered across Canada in 2–5 business days, tracked
  • Temperature-controlled packaging where the product needs it
  • Free shipping on orders over $120
  • Prices in CAD · pay by Interac e-Transfer
Format
Lyophilised powder in a sealed vial
Strength
5 mg per vial
Storage
Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
Reconstitution
2 mL bacteriostatic water for this 5 mg vial (2.5 mg/mL)
Route in research
Subcutaneous
SKU
DS5

Handling

  1. 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
  2. 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
  3. 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
Purity
High-performance liquid chromatography (HPLC), by an independent laboratory
Identity
Mass spectrometry, on the same batch
How often
Every batch
COA
The certificate of analysis is matched to the lot code printed on your vial
Evidence
Early clinical

Check your lot

Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.

Early clinicalDSIP has been characterized in laboratory and animal work and examined in small human studies, including a 1981 clinical trial on disturbed human sleep, but it has not progressed to large late-stage trials.

What research examines

  • Delta-wave (slow-wave) sleep activity
  • Sleep architecture in disturbed human sleep
  • Interaction with corticotropin-releasing stress-axis signaling
  • Stress-hormone regulation
  • Gastrointestinal absorption and gut immunoreactivity in animal models

Reported in studies

  • Human safety data are limited
  • Adverse events are not summarized in the cited studies
  • Its mechanism of action remains incompletely resolved, per published reviews
Read the full research page· 5 cited studies

Published research protocols

200 mcg, daily, pre-sleep

Research protocols have used 100–500 mcg per administration, once daily (pre-sleep), in 8-week blocks with 4 weeks off.

For research use only. These figures summarize published research protocols. They are not instructions or medical advice.

Measure with the calculator

CoreX AI

Ask about DSIP

Plain answers, from the basics to the studies.

Research information, not medical advice.

Often researched with DSIP

Researched for focus, mood & sleep.

Shop Focus, mood & sleep

FAQ

Questions, answered

  • DSIP, or Delta Sleep-Inducing Peptide, is a nonapeptide, a chain of nine amino acids, first identified for its association with delta-wave sleep. Its amino-acid sequence and synthesis were described in 1978. Research has since examined its relationship with sleep architecture and with the regulation of stress hormones. Reviews spanning several decades have described it as a compound of continuing scientific interest whose biological role is still not fully resolved.

  • Research has investigated DSIP for an influence on the slow-wave phase of sleep, the deepest stage of the sleep cycle, which is marked by delta-wave activity on EEG. It has also been explored for interaction with corticotropin-releasing signaling, part of the hormonal cascade governing the stress response. A 2006 review described DSIP as a still unresolved riddle, reflecting that a precise receptor and mechanism have not been firmly established.

  • Studies have examined DSIP in relation to delta-wave sleep, sleep architecture, and stress-axis signaling. A small 1981 clinical trial looked at the influence of synthetic DSIP on disturbed human sleep. Animal work has studied the absorption of DSIP-like material from the gastrointestinal tract of neonatal rats, and other research has described DSIP-like immunoreactivity in gut tissue alongside known peptide hormones. Materials research has also explored entrapping DSIP in porous matrices.

  • Human safety data for DSIP are limited. The available human research consists of small studies, and adverse events are not summarized in the cited studies. Published reviews emphasize that its mechanism remains incompletely understood, which limits firm conclusions about its safety profile. DSIP is supplied by CoreX for laboratory research use only, and its safety has not been established through large controlled trials.

  • Research protocols have used 100 to 500 mcg per administration, once daily before sleep, in 8-week blocks followed by 4 weeks off, with subcutaneous administration described as the route. These figures reflect what research protocols have reported and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. DSIP is sold for research use only.